Exagen (XGN) Competitor Comparison
We are evaluating the key criteria listed to compare Exagen (XGN) against its competitors in the Diagnostics & Research industry.
Market Capitalization
52 / 58Gross Profits
43 / 52Total Revenue
43 / 57EBITDA
39 / 56Free Cashflow
43 / 56Quick Ratio
14 / 57Earnings per Share
36 / 56Dividend yield
0 / 9Total Cash
45 / 57Performance 3 years
38 / 58Performance 5 years
47 / 58Performance 10 years
42 / 58Linearity 3 years
38 / 58Linearity 5 years
44 / 58Linearity 10 years
24 / 58Total Rank
34 / 58Dividend Rank
50 / 58Valuation Rank
9 / 58Piotroski Rank
57 / 58Muliplier Rank
14 / 58Total Cash - XGN ranking 45 / 57
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.